Medico Remedies Past Earnings Performance
Past criteria checks 3/6
Medico Remedies has been growing earnings at an average annual rate of 35.4%, while the Pharmaceuticals industry saw earnings growing at 13.9% annually. Revenues have been growing at an average rate of 9.1% per year. Medico Remedies's return on equity is 16.3%, and it has net margins of 5.9%.
Key information
35.4%
Earnings growth rate
35.5%
EPS growth rate
| Pharmaceuticals Industry Growth | 17.5% |
| Revenue growth rate | 9.1% |
| Return on equity | 16.3% |
| Net Margin | 5.9% |
| Next Earnings Update | 12 Nov 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Medico Remedies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 1,442 | 85 | 60 | 0 |
| 31 Mar 24 | 1,449 | 83 | 60 | 0 |
| 31 Dec 23 | 1,316 | 70 | 59 | 0 |
| 30 Sep 23 | 1,407 | 78 | 59 | 0 |
| 30 Jun 23 | 1,388 | 82 | 58 | 0 |
| 31 Mar 23 | 1,404 | 72 | 58 | 0 |
| 31 Dec 22 | 1,447 | 75 | 61 | 0 |
| 30 Sep 22 | 1,360 | 63 | 65 | 0 |
| 30 Jun 22 | 1,251 | 51 | 57 | 0 |
| 31 Mar 22 | 1,210 | 48 | 60 | 0 |
| 31 Dec 21 | 1,191 | 33 | 60 | 0 |
| 30 Sep 21 | 1,194 | 28 | 55 | 0 |
| 30 Jun 21 | 1,207 | 19 | 51 | 0 |
| 31 Mar 21 | 1,224 | 26 | 49 | 0 |
| 31 Dec 20 | 1,149 | 25 | 45 | 0 |
| 30 Sep 20 | 1,074 | 25 | 41 | 0 |
| 30 Jun 20 | 980 | 20 | 40 | 0 |
| 31 Mar 20 | 886 | 16 | 39 | 0 |
| 31 Dec 19 | 938 | 18 | 36 | 0 |
| 30 Sep 19 | 990 | 19 | 33 | 0 |
| 30 Jun 19 | 984 | 17 | 34 | 0 |
| 31 Mar 19 | 977 | 16 | 34 | 0 |
| 31 Dec 18 | 855 | 14 | -13 | 0 |
| 30 Sep 18 | 732 | 13 | 40 | 0 |
| 30 Jun 18 | 671 | 12 | 40 | 0 |
| 31 Mar 18 | 610 | 12 | 41 | 0 |
| 31 Mar 17 | 544 | 16 | 45 | 0 |
| 31 Mar 16 | 667 | 11 | 100 | 0 |
| 31 Mar 15 | 510 | 8 | 89 | 0 |
| 31 Mar 14 | 449 | 6 | 81 | 0 |
Quality Earnings: 540937 has high quality earnings.
Growing Profit Margin: 540937's current net profit margins (5.9%) are higher than last year (5.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 540937's earnings have grown significantly by 35.4% per year over the past 5 years.
Accelerating Growth: 540937's earnings growth over the past year (4.2%) is below its 5-year average (35.4% per year).
Earnings vs Industry: 540937 earnings growth over the past year (4.2%) did not outperform the Pharmaceuticals industry 19.5%.
Return on Equity
High ROE: 540937's Return on Equity (16.3%) is considered low.